Maven Securities LTD Uni Qure N.V. Transaction History

Maven Securities LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$26.01 - $38.22 $1.18 Million - $1.74 Million	-45,481 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$29.97 - $37.17 $3.59 Million - $4.45 Million	-119,804 Reduced 72.48%	45,481 $1.4 Million
Q1 2021 May 17, 2021	BUY	$29.24 - $42.03 $1.44 Million - $2.07 Million	49,200 Added 42.38%	165,285 $5.57 Million
Q4 2020 Feb 12, 2021	BUY	$35.35 - $50.67 $4.1 Million - $5.88 Million	116,085 New	116,085 $4.31 Million

141

33.7M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $212M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.